-
-
-
-
-
-
-
Maravai LifeSciences (MRVI) Reports In-Line Q3 EPS
-
-
-
-
-
-
-
Maravai LifeSciences (MRVI) names Rajesh Asarpota as CFO
-
-
-
-
-
-
-
MRVI DEADLINE ALERT: Maravai LifeSciences (MRVI) Investors with Losses Encouraged to Contact Hagens Berman Before May 5th Deadline in Securities Class Action
-
-
-
-
-
-
-
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Maravai LifeSciences
-
-
-
-
-
-
-
Maravai LifeSciences (MRVI) Earnings Call Raises Questions Amid Legal Allegations - Hagens Berman
-
-
-
-
-
-
-
Maravai LifeSciences Holdings, Inc. (MRVI) Admits to Incorrect Revenue Recognition, Ineffective Internal Controls; Class Action Pending - Hagens Berman
-
-
-
-
-
-
-
MRVI INVESTOR ALERT: Maravai LifeSciences Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
-
1,197,287 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

